Temazepam and Dermatitis exfoliative aggravated - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative aggravated is reported as a side effect among people who take Temazepam (temazepam), especially for people who are female, 60+ old, also take Furosemide, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Dermatitis exfoliative aggravated when taking Temazepam. It is created by eHealthMe based on reports of 40,724 people who have side effects when taking Temazepam from the FDA, and is updated regularly.

What is Temazepam?

Temazepam has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,106 Temazepam users. Check the latest studies of Temazepam.

What is Dermatitis exfoliative aggravated?

Dermatitis exfoliative aggravated (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 623 drugs and 336 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative aggravated.

On Jul, 26, 2026

40,724 people reported to have side effects when taking Temazepam.
Among them, 25 people (0.06%) have Dermatitis exfoliative aggravated.

Could Temazepam cause Dermatitis exfoliative aggravated?

Among these 25 people:

What is the gender of people who have Dermatitis exfoliative aggravated when taking Temazepam? *

female: 52.17 %
male: 47.83 %

What is the age of people who have Dermatitis exfoliative aggravated when taking Temazepam? *

What are other drugs people take besides Temazepam? *

What are other side effects people have besides Dermatitis exfoliative aggravated? *

Fever: 10 people, 40.00%
Rashes (redness): 9 people, 36.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 28.00%
Back Pain: 6 people, 24.00%
High Blood Pressure: 5 people, 20.00%
Oedema Peripheral (superficial swelling): 5 people, 20.00%
Itching: 5 people, 20.00%
Pneumonia: 5 people, 20.00%
Fatigue (feeling of tiredness): 5 people, 20.00%
Arrhythmias (irregular heartbeat): 5 people, 20.00%

What are the existing conditions these people have? *

Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 4 people, 16.00%
High Blood Pressure: 4 people, 16.00%
Multiple Myeloma (cancer of the plasma cells): 4 people, 16.00%
Immunodeficiency Disorders: 4 people, 16.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 8.00%
Constipation: 2 people, 8.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 8.00%
Fungal Infection: 2 people, 8.00%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 2 people, 8.00%
Stress And Anxiety: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Temazepam and have Dermatitis exfoliative aggravated?

- Check whether Dermatitis exfoliative aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temazepam:

Temazepam (42,106 reports)

Browse all side effects of Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative aggravated:

Dermatitis exfoliative aggravated (623 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative aggravated:

Dermatitis exfoliative aggravated (336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Temazepam) and Temazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.